Related Articles
β-Elemene enhances susceptibility to cisplatin in resistant ovarian carcinoma cells via downregulation of ERCC-1 and XIAP and inactivation of JNK
Cisplatin and phorbol ester independently induce ERCC-1 protein in human ovarian carcinoma cells.
Comparison of two human ovarian carcinoma cell lines (A2780/CP70 and MCAS) that are equally resistant to platinum, but differ at codon 118 of the ERCC1 gene.
Gli1 contributes to cellular resistance to cisplatin through altered cellular accumulation of the drug
The tumor suppressor OVCA1 is a short half‑life protein degraded by the ubiquitin‑proteasome pathway